InsiderPulse| Date | Owner | Role | Type | Shares | Price | Value | Owned After | ||
|---|---|---|---|---|---|---|---|---|---|
| 2026-04-27 | Mancini Anthony | See Remarks | Sale | 3,120 | $132.41 | $413K | 54.4K | View ↗ | |
| 2026-03-25 | Mancini Anthony | See Remarks | Sale | 37.5K | $95.56 | $3.58M | 54.4K | View ↗ |
No annual data found.
Revolution Medicines to Report Financial Results for First Quarter 2026 After Market Close on May 6, 2026
Erasca Shares Plunge 48% After Trial Patient Death, Patent Dispute Emerges
Revolution’s on a pancreatic cancer winning streak. What comes next for the biotech?
Stock Market Today, April 28: Erasca Plunges After Patient Death in Early Cancer Drug Trial